Objective: The importance of psychosocial factors in patients with Functional Bowel Disorders (FBD) has been well-established. However, most psychosocial measures used in research with FBD patients were not designed or validated on this population. A recent international team report recommended that psychosocial measures be developed to increase our understanding and treatment of FBD. The purpose of this study was to develop a reliable and valid instrument designed specifically to assess cognitions of patients with FBD. Method: An initial set of 204 scale items was generated from a large pool of thought diaries from patients diagnosed with FBD. [terns were additionally refined using several methods, including consultation with a multidisciplinary team of international experts on FBD. The remaining 95 items were administered, along with a set of validating questionnaires, to a new sample of 75 FBD patients in Canada and the United States. Results: The findings indicate that the final 25-item scale has high reliability (Cronbach's a = .93; inter-item correlation = .36); high concurrent criterion validity evidenced by the correlation of the scale with a global rating of life interference caused by bowel symptoms (r = .71; p < .001); acceptable convergent validity evidenced by the correlation of the scale with the Dysfunctional Attitudes Scale (/• = .38; p < .01); high content validity and face validity; and minimal social desirability contamination (r = .15; NS). Conclusions: The Cognitive Scale for Functional Bowel Disorders is a valid and reliable scale that can be used as an outcome measure in evaluating the efficacy of different forms of psychotherapeutic intervention for FBD, and can also serve as a helpful assessment tool for health professionals working with patients diagnosed with FBD. Key words: functional bowel disorders, scale development, cognitive-behavioral therapy, irritable bowel syndrome. FBD = functional bowel disorders; DAS = dysfunctional attitudes scale; IBS = irritable bowel syndrome; CS-FBD = cognitive scale for functional bowel disorders; ENS = enteric nervous system; CNS = central nervous system.
INTRODUCTION
FBD are very common, chronic disorders that significantly interfere with quality of life (1) . They are estimated to affect 8% to 19% of the general adult population in a given year (2-5,) . Although most affected individuals do not seek medical attention, those who do seek medical consultation and treatment for these disorders make extensive use of the health care system. FBD accounts for 3.5 million physician visits every year and for 20% to 70% of all referrals made to gastroenterologists in Western societies (6) (7) (8) (9) (10) (11) (12) (13) .
The cost to the health care system and the general economic impact of FBD is considerable. These disorders lead to over 2 million prescriptions per year in the United States (14) and are associated with unnecessary and often harmful tests, procedures, and surgeries (15, 16) . FBD have been ranked as the second most common cause of industrial absenteeism caused by illness, next to the common cold (14, 17) , and they account for 8 billion dollars of physician, laboratory, and radiology charges annually in the United States white population. All of these factors demonstrate the importance of cost-effective evaluation and treatment of patients with FBD.
Consensual criteria now exist (18) to diagnose FBD, depending on the predominant symptoms of functional constipation, functional diarrhea, and chronic functional abdominal pain. However, no physiological or psychosocial markers for FBD have been identified. Rather, several predisposing, precipitating, and perpetuating factors have been identified as contributing to the expression and maintenance of FBD. As summarized by Drossman (1) , IBS, the most prevalent and clinically significant diagnostic group, is best conceptualized using a biopsychosocial framework. Symptoms may be generated from physiological disturbances (enhanced motility and visceral sensation), which are closely connected to central nervous system activity (via the central nervous systementeric nervous system axis). The clinical expression of these symptoms (eg, the decision to take medication or seek health care) is strongly influenced by psychosocial factors (13, 19, 20) . For this reason, the high frequency of psychosocial disturbance (eg, psychiatric diagnoses, sexual abuse history) in the absence of modulating factors (eg, social support, coping strategies) reported among IBS patients may, in part, relate to their self-selection into referral practices.
The importance of psychological factors in patients who seek repeated specialized consultation for FBD has been well documented (13, 21) . However, there have been surprisingly few controlled studies investigating psychological treatments for FBD patients. The most common treatment approach to date includes cognitive-behavioral packages (20) . Within the last 12 years, there have been nine controlled studies involving cognitive and/or behavioral therapy packages (22) (23) (24) (25) (26) (27) (28) (29) (30) . In general, studies found a reduction in bowel symptoms and psychosocial distress. However, to date, no study has measured the association between cognitive change and reduction in bowel symptoms using validated cognitive measures for FBD. Although these studies are promising in that they support cognitive-behavioral principles in the treatment of FBD, they suffer from substantial methodological flaws that limit the interpretation of their findings (20) . One of the most serious limitations of work in this area is that most assessment and outcome measures used in research with patients having FBD were not designed and validated on this population. The majority of psychosocial questionnaires were normalized on psychiatrically ill or healthy populations. A recent international team report (31) recommended that measures be developed that are relevant to the psychosocial concerns of patients with FBD.
A review of the literature indicates that there are no
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standardized measures available that have been designed to assess cognitions of FBD patients. Accordingly, it is difficult to assess the efficacy of cognitive-behavioral therapies when there is no adequate measure of change in the primary measure of conceptual and clinical importance (ie, cognition). The present study was designed to address this need by developing a reliable and valid instrument to assess the cognitions of patients diagnosed with functional bowel disorders. The method of scale development used in this study is based on the multistage method of Jackson (32) and has been used effectively in several studies (33) (34) (35) (36) (37) . This method stresses the use of validating measures in each stage of development.
M E T H O D Item Generation
The goal of this phase was to develop a set of candidate items for consideration for inclusion in the Cognitive Scale for Functional Bowel Disorders.
The initial items were generated from the diaries of Automatic Thought Records of 39 patients (mean age = 35.06, SD 11.02; gender = 27 F, 12 M) who participated in a separate study investigating the effects of cognitive-behavioral group therapy for functional bowel disorders (38) . All participants met diagnostic criteria for a functional bowel disorder (16) before participation in the study and were referred from gastroenterologists at University of Toronto teaching hospitals. The participants completed diaries of automatic thoughts that are defined as " . . . the moment-to-moment, unplanned thoughts. . . that flow through our minds throughout the day" (Ref. 39, p.5) . In these diaries, the patients documented their cognitions in first-person format. Examples of the patients' cognitions were, "I will be very embarrassed if I have to leave a meeting with my superiors to go to the bathroom" (suggesting that FBD patients may experience a sense of embarrassment that is related to their physical symptoms), and "I'm worried I won't be able to concentrate because of the pain" (reflecting cognitions concerning pain).
Item Extraction
Two authors of this study (N.S., F.D.) independently reviewed the automatic thought records and extracted 204 candidate items on the basis of recorded cognitions of the FBD patients. There was more than 90% agreement between the two raters on which statements contained automatic thoughts.
The items were then presented to our research team composed of the present authors. We identified any items that were found to be redundant, ambiguous, double-barreled (ie, having more than one thought within one item), or unrelated to FBD. We also found that several of the cognitions from different respondents were almost identical; consequently, some items were eliminated. Also, doublebarreled items were rewritten as two single items. This review produced 99 candidate items to be considered for inclusion in the final scale.
We then categorized each item within a theme. The themes were developed to cover the domain of cognitions relevant to patients with FBD. Themes were derived from several sources, including the automatic thought records, literature reviews, and discussions among our own group of researchers and clinicians, as well as with other health care professionals involved in FBD. These themes (and examples of items theoretically related to the theme) include: bowel performance anxiety ("I often worry that I won't be able to rely on my bowels to function properly"); control ("My bowel symptoms make me feel out of control"); pain ("When I have bowel symptoms, I'm in agony"); perfectionism ("It's important to do my absolute best at everything I try"); anger/frustration ("I am constantly frustrated by my bowel symptoms"); self-efficacy ("I feel that my bowel symptoms are too much for me to handle"); social approval ("I hate the thought of making a fool of myself in front of other people"); embarrassment/shame ("It is extremely embarrassing to have to keep going to the bathroom"); heightened sensitivity to social rules and norms ("The idea of being late upsets me"); and self-nurturance ("I feel guilty if I spend time nurturing myself").
Item Refinement
We generated an additional five items on the basis of our clinical and research experience in the area of functional bowel disorders (eg, "Having bowel problems makes traveling around the city unbearable"). The resulting set of 104 items were then reviewed by an internal panel of colleagues who were instructed to evaluate the items and to suggest relevant areas or items which should be added to the scale. This review resulted in a set of 111 items. These ] 11 items were examined by a multidisciplinary team of 12 experts (gastroenterologists, psychologists, psychiatrists) who are involved in the research and treatment of functional bowel disorders at various universities in Canada, the United Kingdom, and the United States. These experts rated each candidate item on a scale from 0 to 10, with 0 indicating that the item definitely should not be included in the scale and 10 indicating that the item definitely should be included in the scale. Experts were also asked to examine each item for clarity, ambiguous meaning, more than one meaning in a sentence, or double-negative statements. They were asked to write any suggested changes in the space below the items. On the basis of consensus among experts' ratings, we deleted items that were not rated as relevant to concerns of functional bowel disorder patients. The result was a set of 95 candidate items. The raters were also asked to suggest any additional themes or items that they believed should be included in the scale. Additional suggested themes and items were disease conviction (eg, "I worry that my doctors have not accurately diagnosed the cause of my bowel symptoms") and concerns about odor (eg, "I am embarrassed to use public bathrooms because of the foul smell").
Scale Selection and Validation
The goal of this phase was to select and validate the CS-FBD.
Participants
Research participants were 75 patients drawn from a referral base of university teaching hospitals in Canada and the United States. Eighty-nine percent of the sample were women; this is consistent with die percentage of women described in previous studies of FBD populations (16) . The mean age of the sample was 41.04 (SD = 11.24). Each of the participants had received a diagnosis of a functional bowel disorder, with 72 having irritable bowel syndrome, 1 having functional constipation, and 2 having FBD unspecified. Additional demographics for the sample can be found in Table 1 . These demographics are similar to other samples of FBD patients in North America (16).
Materials
Cognitive Scale Candidate Items. The 95 candidate items produced in the initial phases of the item generation and refinement were presented in a Likert-type scale format. Respondents indicated their agreement with each statement on a seven-point scale ranging from 1, disagree strongly, to 7, agree strongly. Participants were asked to indicate the extent to which each statement applied to them over the past month.
Interference Rating. This was a single-item question that asked each participant to indicate the extent to which bowel symptoms had interfered with their life. This was a rating from 0 ("not at all") to 10 ("completely"), which assessed the criterion validity of the completed scale by examining the relationship between the completed scale and this measure of current interference with life caused by bowel symptoms. This rating was developed to be a measure of concurrent criterion validity.
Dysfunctional Attitudes Scale. The DAS was used in this study to assess the convergent validity of our Cognitive Scale. This 40-item Psychosomatic Medicine 60:492-497 (1998) scale measures the presence of dysfunctional attitudes that relate to cognitive vulnerability and depression (40) . Reported psychometric properties of the DAS include internal consistency coefficients of .79 to .93, and test-retest correlations of .79 to .81. Demonstrations of construct validity include depressed individuals scoring higher on this measure than nondepressed controls, and DAS scores being predictive of the reoccurrence of depression in remitted depressed patients. Because a substantial percentage of FBD patients also experience psychological symptoms, including depression, we hypothesized that our Cognitive Scale for Functional Bowel Disorders would show a positive correlation with this measure. We expected, however, that this correlation would not be so strong as to indicate that our scale is overly similar to the DAS. Jackson Social Desirability Scale. The 16-item Jackson Social Desirability Scale (32) was included to test the candidate items and the subsequently developed scale for social desirability contamination (ie, the tendency to respond in a manner likely to present oneself favorably to others). Respondents endorsed items on this scale as either True or False, and a total social desirability score was computed for each respondent. A correlation of .30 or higher between the Jackson scale score and an item on the scale in question is considered to be evidence of a social desirability bias.
Procedure
The participants were asked to complete the set of questionnaires on a one-time basis. They were advised of the purpose of the study (ie, to develop a scale designed to assess cognitions related to functional bowel disorders) and were assured that their participation was completely voluntary and that their responses were anonymous. They completed an informed consent form before participation and were assured that they could leave blank any items that they did not wish to answer. Participants also were offered the opportunity to provide any feedback on the study. As well, they were told that they could receive copies of the results of the study if they provided a mailing address.
RESULTS

Scale Selection
The following statistical analyses were performed to select items for the scale. One of the issues involved in the scale construction is the assurance of the reliability of the scale as a whole. Thus, as a first step, each item was examined to determine how well it related to the total scale (Cronbach's a). An item was eliminated if the inclusion of that item resulted in a lowering of the Cronbach's a to a value of less than .80 (41) . Second, items were retained if they had correlations of less than .20 with social desirability. Third, a principal components factor analysis was performed on the items that met the above criteria. Examination of the loading of the items in the factor analysis were taken into consideration in the final selection of the items (the minimum criteria for inclusion in the scale was .40).
The 95 candidate items were examined to select the items for the final scale. Initial principal components factor analysis was performed to examine the loadings of items on different possible factors. The results of this analysis, along with the a priori themes, were used in selecting items. Selection was also based on the item-total correlations (ranging from r -.31 to r = .67) (see Table 2 ). Twenty-five items were selected and were examined for redundancy and content (ie, that a priori themes were represented in the final scale.) These final 25 items compose the Cognitive Scale for Functional Bowel Disorders (CS-FBD). A principal components factor analysis stipulating varimax rotation was performed on this scale. One major factor accounted for the bulk of the total variance (ie, 40%) of the 25 items. There were two smaller factors (9% and 5% respectively). Both of these factors were not clearly interpretable. It did not seem to be justified to label these minor factors as subscales. Forcing a single factor solution resulted in loadings of .47 and greater for 22 of the 25 items. The three remaining items had loadings between .31 and .37. These items were retained on the basis of their relevance to a priori themes. These results suggest that the Cognitive Scale is a unidimensional measure. This final measure is scored using a Likert scale for each item ranging from 1 (strongly disagree) to 7 (strongly agree) with no reverse-scored items. This produces a total score for the scale ranging from 25 to 175.
Reliability and Validity of the Cognitive Scale for Functional Bowel Disorders
The final scale was examined to confirm that it met the criteria for internal consistency (minimum .80 Cronbach's a) and inter-item correlations (.20-.40). Secondly, it was expected that the final scale would not show evidence of social desirability contamination (ie, a correlation of less than .20 with the Jackson Social Desirability Scale). Finally, an examination was made of the relationship between the final scale and the validating measures. It was expected that there would be a positive correlation between the scale and the measure of convergent validity (DAS), and a positive correlation between the scale and the measure of criterion validity (the Interference Rating).
Reliability. Analysis performed on the Cognitive Scale for Functional Bowel Disorders resulted in a Cronbach's a of .93. The inter-item correlation of the scale was .36. This is well within the range of .20 and .40 that Briggs and Cheek (42) suggest as the optimal level of item homogeneity for a scale. " Interference = rating of extent to which symptoms interfere with life; DAS = dysfunctional attitudes scale; JSD = Jackson social desirability scale.
These findings indicate that the scale has a high level of internal consistency. Assessment of Social Desirability Contamination. The correlation between the Cognitive Scale for Functional Bowel Disorders and the total social desirability score was low, r(74) = .15, NS. This low nonsignificant correlation indicated that the Cognitive Scale for Functional Bowel Disorders does not seem to be contaminated by social desirability. We, therefore, suggest that the participants' responses to the items of the scale reflected their true cognitions about the content of the items and were not unduly influenced by a desire to present themselves favorably.
Validation Analyses. The scale demonstrated acceptable convergent validity evidenced by the correlation of the scale with the Dysfunctional Attitudes Scale, r(75) =.38; p < .01. The scale had high concurrent criterion validity evidenced by the correlation of the scale with the global rating of life interference due to bowel symptoms, r(75) =.71,/? < .001. As well, the correlation of the 25-item scale with an ad hoc scale consisting of the remainder of the candidate items was r(75) = .86, p < .001; this indicated a strong relationship between the selected items and other potential items that were written to demonstrate concerns of FBD patients but which were not included in the final scale.
DISCUSSION
The outcome of our study is a scale that fulfilled our goal of developing a valid, reliable measure to assess cognitions of particular relevance to FBD patients. In developing this measure, we followed the recommended method of Jackson (32) and constructed a scale that can be readily administered to patients diagnosed with a functional bowel disorder.
Our findings indicate that the Cognitive Scale for Functional Bowel Disorders is a reliable measure that is not contaminated by social desirability. There is strong empirical and theoretical evidence for the validity of this measure. Validity was established in both the item generation and scale selection phases of this study. The content validity of the scale is supported by the fact that items are included that: a) capture the concerns expressed by patients in their automatic thought records, and b) correspond to a priori themes relevant to functional bowel disorders. Evidence for face validity is based on: a) the fact that mere examination of the items indicates that the items involved deal with concerns related to bowel problems; b) the very high correlation between the scale and an ad hoc scale consisting of items developed to represent concerns voiced by patients with functional bowel syndrome; and c) the affirmation from the 75 patients who responded to all 95 items that the items did indeed address functional bowel-related concerns. The scale also has good convergent validity, as demonstrated by the relationship with the Dysfunctional Attitudes Scale. The scale has high concurrent criterion validity, as evidenced by the high correlation between the scale and a global rating of life interference caused by bowel symptoms. Correlating one scale with a scale that consists of a single item is not uncommon in the quality of life literature, for example (43) (44) (45) (46) (47) .
There are several aspects of the present study that are particular strengths. First, the items represent the thoughts of patients with functional bowel disorders, inasmuch as we a) used the content of Automatic Thought Records of a sample of FBD patients in the initial item generation for the scale, and b) administered the scale, along with the validating questionnaires, to a different sample of FBD patients and used their responses in the final selection of scale items. A second strength of this study is that we included a multidisciplinary team of international experts on FBD in developing and refining items for the scale; the inclusion of gastroenterologists, psychologists, psychiatrists, and other researchers and clinicians in the process of scale development greatly enhanced the content and design of the final measure. Another strength in the development of this scale was that we included input from experts and patients from different sites within Canada and the United States. This process has increased the applicability of the scale to different populations of FBD patients.
A limitation in the development of the Cognitive Scale for Functional Bowel Disorders involves its possible lack of generalizability to individuals with FBD who do not seek treatment for their conditions. To date, most studies on the psychosocial factors in FBD have investigated clinic samples, and the majority of findings and theories regarding FBD thus apply almost solely to a subgroup of individuals with FBD who are seen by specialists. As well, reports indicate that the psychosocial profile of people with FBD who do not seek medical attention for their symptoms differs from that of their help-seeking counterparts (48) . Furthermore, we included only patients diagnosed with FBD in this study. Therefore, this scale may be most relevant to individuals with FBD who have been seen by gastroenterologists. It is particularly important to target this subgroup, which has been unable to cope effectively with FBD and is vulnerable to unnecessary and often harmful procedures and surgeries. Additional studies will need to determine the specificity of these cognitions to other patient groups.
We expect that the Cognitive Scale for Functional Bowel Disorders will be found to have many uses, both clinically and empirically. This measure can be used as an outcome measure in assessing the efficacy of different forms of psychotherapeutic intervention for FBD. This scale also can serve as a helpful assessment tool for professionals working in mental health or in gastroenterology with patients diagnosed with FBD. We would suggest that mental health practitioners, in particular, could explore with patients their responses to the scale items as possible areas for intervention. Such an intervention could help FBD patients to examine the sources of their cognitions and to create changes in their lives that would enable them to respond to stressors and difficulties in more beneficial ways. Finally, this scale can be used as a psychometrical ly sound research tool for increasing the understanding of the psychosocial dimension of FBD. By using this scale with various populations of FBD patients, we can enhance the conceptualization of this condition and contribute to various modes of treatment. 
